the host's CRISPR locus which is then transcribed into small CRISPR RNAs (crRNAs) that after hybridizing with a trans-activating crRNA (tracrRNA) direct the degradation of invading DNA by Cas endonucleases. In 2013, a joint research team from the Rockefeller University and the MIT coupled the CRISPR/Cas9 system of Streptococcus pyogenes with the lambda Red recombineering system to introduce point mutations in E. coli and Streptococcus pneumoniae with an efficiency of 65-100% (11). Other research teams have expanded this technique to introduce gene-size insertion and deletions (12) . The importance of such a high efficiency is twofold. First, it eliminates the need for selectable markers as transformants can easily be detected by colony PCR screening. Second, it implies that it may be possible to integrate constructs much larger than those possible with lambda Red system alone. In fact, a recent study has demonstrated that this technique is capable of integrating 10 kb constructs with an efficiency of approximately 50% (13) . These methods are also far less complicated than other techniques and the whole process can be completed in a single day.
Although CRISPR-based recombineering techniques are still in the early stages of development, they have already produced astonishing results. These methods may finally provide biologists with the much needed tools for large scale manipulation of E. coli genome and, probably, revolutionize the fields of molecular genetics, metabolic engineering and synthetic biology.
